MAVS-Mito Citations (3)

Originally described in: Peroxisomes are signaling platforms for antiviral innate immunity.
Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC Cell. 2010 May 14;141(4):668-81. Epub 2010 May 6. PubMed Journal

---

Articles Citing MAVS-Mito

Articles
Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells. Ding S, Zhu S, Ren L, Feng N, Song Y, Ge X, Li B, Flavell RA, Greenberg HB. Elife. 2018 Nov 21;7. pii: 39494. doi: 10.7554/eLife.39494. PubMed
Viperin interacts with PEX19 to mediate peroxisomal augmentation of the innate antiviral response. Khantisitthiporn O, Shue B, Eyre NS, Nash CW, Turnbull L, Whitchurch CB, Van der Hoek KH, Helbig KJ, Beard MR. Life Sci Alliance. 2021 Jun 9;4(7). pii: 4/7/e202000915. doi: 10.26508/lsa.202000915. Print 2021 Jul. PubMed
Telomere-to-mitochondria signalling by ZBP1 mediates replicative crisis. Nassour J, Aguiar LG, Correia A, Schmidt TT, Mainz L, Przetocka S, Haggblom C, Tadepalle N, Williams A, Shokhirev MN, Akincilar SC, Tergaonkar V, Shadel GS, Karlseder J. Nature. 2023 Feb;614(7949):767-773. doi: 10.1038/s41586-023-05710-8. Epub 2023 Feb 8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.